111 related articles for article (PubMed ID: 15821442)
1. Alpha v integrin affinity/specificity and antiangiogenesis effect of a novel tetraaza cyclic peptide derivative, SU015, in various species.
Mousa SA
J Cardiovasc Pharmacol; 2005 May; 45(5):462-7. PubMed ID: 15821442
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
3. Alphavbeta3 integrin binding affinity and specificity of SM256 in various species.
Mousa SA; Lorelli W; Mohamed S; Batt DG; Jadhav PK; Reilly TM
J Cardiovasc Pharmacol; 1999 Apr; 33(4):641-6. PubMed ID: 10218736
[TBL] [Abstract][Full Text] [Related]
4. Biological and molecular properties of a new alpha(v)beta3/alpha(v)beta5 integrin antagonist.
Belvisi L; Riccioni T; Marcellini M; Vesci L; Chiarucci I; Efrati D; Potenza D; Scolastico C; Manzoni L; Lombardo K; Stasi MA; Orlandi A; Ciucci A; Nico B; Ribatti D; Giannini G; Presta M; Carminati P; Pisano C
Mol Cancer Ther; 2005 Nov; 4(11):1670-80. PubMed ID: 16275988
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiogenesis in vitro and in vivo: comparison of the relative activities of triflavin, an Arg-Gly-Asp-containing peptide and anti-alpha(v)beta3 integrin monoclonal antibody.
Sheu JR; Yen MH; Kan YC; Hung WC; Chang PT; Luk HN
Biochim Biophys Acta; 1997 Oct; 1336(3):445-54. PubMed ID: 9367172
[TBL] [Abstract][Full Text] [Related]
6. Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802.
Mousa SA; Olson RE; Bozarth JM; Lorelli W; Forsythe MS; Racanelli A; Gibbs S; Schlingman K; Bozarth T; Kapil R; Wityak J; Sielecki TM; Wexler RR; Thoolen MJ; Slee A; Reilly TM; Anderson PS; Friedman PA
J Cardiovasc Pharmacol; 1998 Aug; 32(2):169-76. PubMed ID: 9700976
[TBL] [Abstract][Full Text] [Related]
7. Src-mediated coupling of focal adhesion kinase to integrin alpha(v)beta5 in vascular endothelial growth factor signaling.
Eliceiri BP; Puente XS; Hood JD; Stupack DG; Schlaepfer DD; Huang XZ; Sheppard D; Cheresh DA
J Cell Biol; 2002 Apr; 157(1):149-60. PubMed ID: 11927607
[TBL] [Abstract][Full Text] [Related]
8. Human alphavbeta3 integrin potency and specificity of TA138 and its DOTA conjugated form (89)Y-TA138.
Mousa SA; Mohamed S
J Cardiovasc Pharmacol; 2005 Feb; 45(2):109-13. PubMed ID: 15654258
[TBL] [Abstract][Full Text] [Related]
9. Abciximab (ReoPro, chimeric 7E3 Fab) demonstrates equivalent affinity and functional blockade of glycoprotein IIb/IIIa and alpha(v)beta3 integrins.
Tam SH; Sassoli PM; Jordan RE; Nakada MT
Circulation; 1998 Sep; 98(11):1085-91. PubMed ID: 9736595
[TBL] [Abstract][Full Text] [Related]
10. Involvement of alpha(v)beta3 integrin-like receptor and glycosaminoglycans in Candida albicans germ tube adhesion to vitronectin and to a human endothelial cell line.
Santoni G; Spreghini E; Lucciarini R; Amantini C; Piccoli M
Microb Pathog; 2001 Oct; 31(4):159-72. PubMed ID: 11562169
[TBL] [Abstract][Full Text] [Related]
11. Bone sialoprotein supports breast cancer cell adhesion proliferation and migration through differential usage of the alpha(v)beta3 and alpha(v)beta5 integrins.
Sung V; Stubbs JT; Fisher L; Aaron AD; Thompson EW
J Cell Physiol; 1998 Sep; 176(3):482-94. PubMed ID: 9699501
[TBL] [Abstract][Full Text] [Related]
12. Heterophilic interactions between cell adhesion molecule L1 and alphavbeta3-integrin induce HUVEC process extension in vitro and angiogenesis in vivo.
Hall H; Djonov V; Ehrbar M; Hoechli M; Hubbell JA
Angiogenesis; 2004; 7(3):213-23. PubMed ID: 15609076
[TBL] [Abstract][Full Text] [Related]
13. Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide.
Erdreich-Epstein A; Shimada H; Groshen S; Liu M; Metelitsa LS; Kim KS; Stins MF; Seeger RC; Durden DL
Cancer Res; 2000 Feb; 60(3):712-21. PubMed ID: 10676658
[TBL] [Abstract][Full Text] [Related]
14. Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells.
Maubant S; Saint-Dizier D; Boutillon M; Perron-Sierra F; Casara PJ; Hickman JA; Tucker GC; Van Obberghen-Schilling E
Blood; 2006 Nov; 108(9):3035-44. PubMed ID: 16835373
[TBL] [Abstract][Full Text] [Related]
15. SB-267268, a nonpeptidic antagonist of alpha(v)beta3 and alpha(v)beta5 integrins, reduces angiogenesis and VEGF expression in a mouse model of retinopathy of prematurity.
Wilkinson-Berka JL; Jones D; Taylor G; Jaworski K; Kelly DJ; Ludbrook SB; Willette RN; Kumar S; Gilbert RE
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1600-5. PubMed ID: 16565398
[TBL] [Abstract][Full Text] [Related]
16. Stable interaction between alpha5beta1 integrin and Tie2 tyrosine kinase receptor regulates endothelial cell response to Ang-1.
Cascone I; Napione L; Maniero F; Serini G; Bussolino F
J Cell Biol; 2005 Sep; 170(6):993-1004. PubMed ID: 16157706
[TBL] [Abstract][Full Text] [Related]
17. Alpha(v)beta3 and alpha(v)beta5 integrin expression in meningiomas.
Bello L; Zhang J; Nikas DC; Strasser JF; Villani RM; Cheresh DA; Carroll RS; Black PM
Neurosurgery; 2000 Nov; 47(5):1185-95. PubMed ID: 11063113
[TBL] [Abstract][Full Text] [Related]
18. A peptidomimetic antagonist of the integrin alpha(v)beta3 inhibits Leydig cell tumor growth and the development of hypercalcemia of malignancy.
Carron CP; Meyer DM; Pegg JA; Engleman VW; Nickols MA; Settle SL; Westlin WF; Ruminski PG; Nickols GA
Cancer Res; 1998 May; 58(9):1930-5. PubMed ID: 9581835
[TBL] [Abstract][Full Text] [Related]
19. Non-cytotoxic cobra cardiotoxin A5 binds to alpha(v)beta3 integrin and inhibits bone resorption. Identification of cardiotoxins as non-RGD integrin-binding proteins of the Ly-6 family.
Wu PL; Lee SC; Chuang CC; Mori S; Akakura N; Wu WG; Takada Y
J Biol Chem; 2006 Mar; 281(12):7937-45. PubMed ID: 16407244
[TBL] [Abstract][Full Text] [Related]
20. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor.
Jones JI; Prevette T; Gockerman A; Clemmons DR
Proc Natl Acad Sci U S A; 1996 Mar; 93(6):2482-7. PubMed ID: 8637900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]